youtube_live
Q3 2026 earnings • released • EPS beat +1.25% • Revenue beat +0.61%
See resultschevron_right
ICLR:NASDAQ
ICON PLC
$209.85
arrow_downward
-2.61%(-5.63) 1D
Oct 30, 11:28:40 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICLR...
Open
$211.52
High
$212.90
Low
$207.01
Mkt. cap
15.72B
Avg. vol.
1.09M
Volume
783.80K
P/E ratio
85.76
52-wk high
$219.00
52-wk low
$66.58
EPS
$2.45
Beta
1.24
Shares outstanding
77.15M
No. of employees
40K
Open
$211.52
High
$212.90
Low
$207.01
Mkt. cap
15.72B
Avg. vol.
1.09M
Volume
783.80K
P/E ratio
85.76
52-wk high
$219.00
52-wk low
$66.58
EPS
$2.45
Beta
1.24
Shares outstanding
77.15M
No. of employees
40K
News stories
From web sources and news partners
The Globe and Mail
·
23 hours ago
Analysts Are Bullish on Top Healthcare Stocks: Icon (ICLR), Beam Therapeutics (BEAM)
Yahoo Finance
·
1 day ago
ICON (ICLR) Could Be 15% Overvalued After Record Wins And Fresh Buyback
Yahoo Finance
·
1 day ago
Icon PLC: Q3 Earnings Snapshot
TradingView
·
1 day ago
What Icon (ICLR) Said on Its Q3 Earnings Call
Profile
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress.
As of December 2025 Icon had approximately 40,100 employees in 55 countries. Wikipedia
About ICON PLC